U.S. FTC launches inquiry into infant formula shortage
Reuters
Published May 24, 2022 03:21PM ET
Updated May 24, 2022 04:20PM ET
WASHINGTON (Reuters) - The Federal Trade Commission said on Tuesday it had launched an inquiry into the ongoing shortage for infant formula in the United States and would examine the pattern of mergers and acquisitions in the formula market.
The inquiry comes after a Feb. 17 recall by top baby formula maker Abbott Laboratories (NYSE:ABT) and the closing of its manufacturing plant in Sturgis, Michigan created one of the biggest baby formula shortages in recent history for U.S. families.
President Joe Biden's administration has sought to relieve the shortage by importing emergency supplies from Europe, the first of which arrived earlier this week. Biden invoked the Cold War-era Defense Production Act to help boost supplies.
In a statement, FTC Chair Lina Khan said the inquiry would "identify the factors that contributed to the shortage or hampered out ability to respond to it."
The inquiry will also examine mergers and acquisitions in the infant formula market "to better understand current concentration, how it came to be, and how that should inform future merger review," the FTC said.
The FTC will also seek public comment on whether the FTC itself or state or federal agencies may have taken steps that contributed to fragile supply chains for infant formula, it added.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.